Your browser doesn't support javascript.
Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID-19, not entirely explaining the increased risk of thrombosis.
de Vries, Judith J; Visser, Chantal; Geers, Lotte; Slotman, Johan A; van Kleef, Nadine D; Maas, Coen; Bax, Hannelore I; Miedema, Jelle R; van Gorp, Eric C M; Goeijenbier, Marco; van den Akker, Johannes P C; Endeman, Henrik; Rijken, Dingeman C; Kruip, Marieke J H A; de Maat, Moniek P M.
  • de Vries JJ; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Visser C; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Geers L; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Slotman JA; Erasmus Optical Imaging Centre, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van Kleef ND; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Maas C; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Bax HI; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Miedema JR; Department of Internal Medicine, Section of Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van Gorp ECM; Department of Pulmonary Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Goeijenbier M; Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van den Akker JPC; Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Endeman H; Department of Viroscience, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Rijken DC; Department of Intensive Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Kruip MJHA; Department of Intensive Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • de Maat MPM; Department of Intensive Care, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
J Thromb Haemost ; 20(6): 1412-1420, 2022 06.
Article in English | MEDLINE | ID: covidwho-1752627
ABSTRACT

BACKGROUND:

Severe acute respiratory syndrome coronavirus 2 infection is associated with an increased incidence of thrombosis.

OBJECTIVES:

By studying the fibrin network structure of coronavirus disease 2019 (COVID-19) patients, we aimed to unravel pathophysiological mechanisms that contribute to this increased risk of thrombosis. This may contribute to optimal prevention and treatment of COVID-19 related thrombosis. PATIENTS/

METHODS:

In this case-control study, we collected plasma samples from intensive care unit (ICU) patients with COVID-19, with and without confirmed thrombosis, between April and December 2020. Additionally, we collected plasma from COVID-19 patients admitted to general wards without thrombosis, from ICU patients with pneumococcal infection, and from healthy controls. Fibrin fiber diameters and fibrin network density were quantified in plasma clots imaged with stimulated emission depletion microscopy and confocal microscopy. Finally, we determined the sensitivity to fibrinolysis.

RESULTS:

COVID-19 ICU patients (n = 37) and ICU patients with pneumococcal disease (n = 7) showed significantly higher fibrin densities and longer plasma clot lysis times than healthy controls (n = 7). No differences were observed between COVID-19 ICU patients with and without thrombosis, or ICU patients with pneumococcal infection. At a second time point, after diagnosis of thrombosis or at a similar time point in patients without thrombosis, we observed thicker fibers and longer lysis times in COVID-19 ICU patients with thrombosis (n = 19) than in COVID-19 ICU patients without thrombosis (n = 18).

CONCLUSIONS:

Our results suggest that severe COVID-19 is associated with a changed fibrin network structure and decreased susceptibility to fibrinolysis. Because these changes were not exclusive to COVID-19 patients, they may not explain the increased thrombosis risk.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumococcal Infections / Thrombosis / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: Jth.15708

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumococcal Infections / Thrombosis / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: Jth.15708